This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Dr. Sonja Merkas, PhD
Founder and CEO at Livinovea
Speaker

Profile

Sonja is the founder of Livinovea, a Switzerland-based consultancy and service provider supporting biotech, pharma, startups, and CDMOs across the drug development and manufacturing value chain. Livinovea integrates science and technology with market positioning and operational strategy — translating complexity into execution and measurable results. Clients engage us for:

1. Operational efficiency, cost reduction, operational excellence

2. Market positioning, business development, and growth strategy

3. CMC, technical transfer, due diligence, and hands-on troubleshooting across RNA, oligonucleotides, small molecules, and peptides

Outside Perspective. Inside Execution. Measurable Results.

Sonja brings over 25 years of experience in the life science industry and consulting, with a focus on oligonucleotide and small molecule therapeutics since 2003 — including 10 years at Novartis leading the oligonucleotide development portfolio. She holds a PhD in Chemistry and a Lean Six Sigma Black Belt.

Agenda Sessions

  • Workshop Leaders' Welcome and Opening Remarks

    9:00am
  • Preclinical Considerations

    10:00am
  • Formulation Design

    11:00am
  • Clinical Considerations

    11:30am